Amgen And Kyowa Kirin Present Positive Late-Breaking Data From Phase 2 Study Of AMG 451/KHK4083 In Adult Patients With Moderate-to-Severe Atopic Dermatitis At EADV Congress
Go back to Amgen And Kyowa Kirin Present Positive Late-Breaking Data From Phase 2 Study Of AMG 451/KHK4083 In Adult Patients With Moderate-to-Severe Atopic Dermatitis At EADV Congress| Amgen Inc (NASDAQ: AMGN) | Delayed: 269.38 -3.63 (1.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $273.01 | 52 Week High | $176.85 | |||
| Open | $273.45 | 52 Week Low | $133.64 | |||
| Day High | $274.35 | P/E | 40.57 | |||
| Day Low | $267.24 | EPS | $6.64 | |||
| Volume | 1,793,803 | |||||
| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 14.65 +0.05 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.60 | 52 Week High | $18.64 | |||
| Open | $14.60 | 52 Week Low | $12.59 | |||
| Day High | $14.85 | P/E | N/A | |||
| Day Low | $14.57 | EPS | $0.00 | |||
| Volume | 49,327 | |||||
| (AMEX: KYKOY) | Delayed: 19.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.80 | 52 Week High | $ | |||
| Open | $19.80 | 52 Week Low | $ | |||
| Day High | $19.80 | P/E | N/A | |||
| Day Low | $19.80 | EPS | $ | |||
| Volume | 162 | |||||
